logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9850273 B1

PDFFull Text
Date of Patent:
Dec. 26, 2017

Filed:

Dec. 03, 2015

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

Applicant:

Evestra, Inc., San Antonio, TX (US);

Inventors:

Klaus Nickisch, Berlin, DE;

Bindu Santhamma, San Antonio, TX (US);

Hareesh Nair, San Antonio, TX (US);

Walter Elger, Berlin, DE;

Assignee:

Evestra, Inc., San Antonio, TX (US);

Attorneys:

Meyertons, Hood, Kivlin, Kowert & Goetzel, P.C.

Mark R. DeLuca

Primary Examiner:

Sahar Javanmard

Int. Cl.
CPC ...
C07J 71/00 (2006.01); C07J 17/00 (2006.01); C07J 21/00 (2006.01); C07J 41/00 (2006.01); C07J 7/00 (2006.01); A61K 31/566 (2006.01); A61K 31/58 (2006.01); C07J 43/00 (2006.01);
U.S. Cl.
CPC ...
C07J 71/0005 (2013.01); A61K 31/566 (2013.01); A61K 31/58 (2013.01); C07J 17/00 (2013.01); C07J 21/00 (2013.01); C07J 43/003 (2013.01); C07J 7/003 (2013.01); C07J 21/006 (2013.01); C07J 41/005 (2013.01); C07J 71/001 (2013.01);
Abstract

Described herein are compositions and methods for hormone replacement therapy that address the shortcomings of the existing methods. Described herein are pharmaceutically effective partial agonistic antiprogestins. The combined application of estrogens (such as estradiol, estriol and conjugated estrogens) and the disclosed partial agonistic antiprogestins can be used in hormone replacement therapy.

Find Patent Forward Citations

Nickisch, Klaus. (2017). Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer (U.S. Patent No. 9850273). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9850273

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…